ce supplement, program errata & addendum


Total Vein Systems. IN-KIND SUPPORT. The ACP solicits in-kind support from multiple vendors in the venous and lymphatics .... Venous Thromboembolism. 1.5.

2017

31 ANNUAL CONGRESS ST

American College of Phlebology 31st Annual Congress November 2 – 5, 2017 Austin, Texas

CME/CE SUPPLEMENT, PROGRAM ERRATA & ADDENDUM EDUCATIONAL GRANT SUPPORT The American College of Phlebology (ACP) gratefully acknowledges the receipt of an educational grant in partial support of this activity from the following companies: Biocompatibles, Inc. Boston Scientific Corporation Medtronic, Inc. Merz North America, Inc. Total Vein Systems

IN-KIND SUPPORT The ACP solicits in-kind support from multiple vendors in the venous and lymphatics industry for workshops and demonstrations that have been developed by the ACP’s Program Planning Committee. The ACP would like to thank the following companies for their in-kind contributions: AngioDynamics – Durable Equipment Argon Medical Devices, Inc. – Durable Equipment; Disposable Supplies Biocompatibles, Inc. – Disposable Supplies Boston Scientific Corporation – Durable Equipment BSN medical Inc. – Disposable Supplies EKOS Corporation – Durable Equipment Hokanson – Durable Equipment Juzo, Inc. – Disposable Supplies Lohmann & Rauscher USA – Disposable Supplies medi USA – Disposable Supplies Mindray North America – Durable Equipment Penumbra, Inc. - Durable Equipment; Disposable Supplies Philips Healthcare – Durable Equipment Sigvaris, Inc. – Disposable Supplies Syris Scientific – Durable Equipment; Disposable Supplies Terason – Durable Equipment TransLite LLC – Durable Equipment United Medical Instruments, Inc. – Durable Equipment VenoSense, Inc. – Durable Equipment

DISCLOSURE INFORMATION In accordance with ACCME Standards for Commercial SupportSM of Continuing Medical Education and the American College of Phlebology’s disclosure policy for CME activities, anyone in a position to control content have been asked to disclose any relationships they have with an ACCME-defined commercial interest that may have relevance to the content of their presentation(s) or role in the activity. The ACCME defines “relevant” financial relationships as financial relationships with a commercial interest in any amount occurring within the past 12 months, and defines commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner. Such disclosure is intended to provide participants with sufficient information to evaluate whether any given presentation has been influenced by the individual’s relationship(s) or financial interest with said company(ies). Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which s/he has a financial relationship. The purpose of identifying and addressing potential conflicts of interest is to ensure a proper balance, independence, objectivity and scientific rigor of the ACP’s educational activities. The ACP does not view the existence of a financial relationship as necessarily implying bias or decreasing the value of participation in CME activities, but must ensure that a financial interest is not a conflict of interest. Note that all faculty disclosures, including invited speaker, abstract presenters, workshop faculty, and moderators, are provided in the 31st Annual Congress mobile app and at http://acp2017. zerista.com. Disclosures for abstract reviewers, clinical content peer-reviewers, planners, and staff are listed below. Name

Activity Role

Commercial Interest

Relationship

Catherine Burdge, APRN

None Program Committee; Faculty; Clinical Content Peer-Reviewer

n/a

Theodore Chambers, MD

Clinical Content PeerReviewer

None

n/a

Yung-Wei Chi, DO, FACPh, FAHA, FSVM

Program Committee; Faculty

VenoSense, Inc.

Board Member; Shareholder

Felipe Collares, MD

Abstract Reviewer

None

n/a

Emily Cummings, MD

Clinical Content PeerReviewer

None

n/a

1. Intersocietal Accreditation Commission – Vein Center Division

1. Board of Directors

Stephen Daugherty, Program Committee; MD, FACS, FACPh, RVT, Faculty RPhS

2. DoctorQA.com

2017

31ST ANNUAL CONGRESS

2. Advisor

Steven Dean, DO, FACP, RPVI

Program Committee; Faculty

Tactile Medical

Scientific Advisory Board; Speakers Bureau

Michael Di Iorio, MD, RPVI, RVT, RPhS

Clinical Content PeerReviewer; Faculty

None

n/a

Antonios Gasparis, MD

Program Committee; Faculty

1. Cook

1. Speaker

2. Medtronic

2. Speaker

3. Terumo

3. Speaker

4. Volcano

4. Speaker

5. Vascular Insights

5. Speaker; Consultant

Sergio Gianesini, MD, PhD

Program Committee; Abstract Reviewer; Faculty

None

n/a

Kenneth Harper, MD, FACS, RPhS

Program Committee; Faculty

1. Covidien

1. Clinical Instructor

2. BTG

2. Advisory Board

3. Comprehensive Vein 3. Co-Owner; Clinical Instructor Training (CVT) Terri Harper, MSN, APRN, FNP-C

Program Committee; Faculty

1. Covidien 2. BTG

1. Clinical Instructor (spouse)

2. Advisor (spouse) 3. Comprehensive Vein 3. Co-Owner; Clinical Training Instructor Paula Heggerick, RVT, RPhS, FSVU

Clinical Content PeerReviewer; Faculty

None

n/a

Ayad Jindeel, MD

Clinical Content PeerReviewer

None

n/a

Margaret Mann, MD

Program Committee; None Faculty; Clinical Content Peer-Reviewer

n/a

Stephen Moss, BA, CHCP

Staff

None

n/a

Diana Neuhardt, RVT, RPhS, FSVU

Faculty; Clinical None Content Peer-Reviewer

n/a

Joseph Raffetto, MD, FACS, FSVM

Abstract Reviewer; Faculty

None

n/a

Johann Chris Ragg, MD

Abstract Reviewer; Abstract Presenter

None

n/a

Stanley Rockson, MD, FACS, FACC

Abstract Reviewer; Faculty

None

n/a

Armen Roupenian, MD, Program Committee; FACS, FACPh, RVT, Faculty RPhS, RPVI

None

n/a

William Schroedter, RPhS, RVT, FSVU

None

n/a

Program Committee; Faculty

2017

31ST ANNUAL CONGRESS

Sonja Stiller-Martin, MD

Clinical Content PeerReviewer

None

n/a

Robert Stoffey, DO, RVT, RPhS, RVS, DABR, DAOBR(CAQNeuroradiology)

Clinical Content PeerReviewer

None

n/a

Julianne Stoughton, MD, FACS

Abstract Reviewer; Faculty

None

n/a

Jorge Ulloa, MD

Abstract Reviewer

None

n/a

Robert WorthingtonKirsch

Faculty; Clinical None Content Peer-Reviewer

n/a

Takashi Yamaki, MD

Abstract Reviewer

n/a

None

CREDITS BY SESSION SESSION THURSDAY, NOVEMBER 2 Track A: Essentials in Venous & Lymphatic Medicine Track B: Essentials in Venous Ultrasound Track C: Pelvic Ultrasound (Hands-On) Track D: Advanced Phlebology & Deep Venous Interventions Track E: Pelvic Ultrasound (Video Viewing) FRIDAY, NOVEMBER 3 7:00 am – 8:00 am Avoiding Complications in Sclerotherapy Chronic Venous Obstruction: A Case-Based Session Meet the Experts: Thermal/Non-Thermal Ablation Techniques Phlebectomy Workshop Sclerotherapy Workshop 8:15 am – 10:15 am General Session 10:45 am – 12:15 pm Abstract Session I Ultrasound Session: Live Scanning Updates in Phlebology 1:15 pm – 3:15 pm Pelvic Venous Disease Sclerotherapy’s Place at the Table

2017

31ST ANNUAL CONGRESS

AMA/ AOA CREDIT

SVU CREDIT

NURSE CE

7 7 7

7 7 7

7 2 0

5.5

5.5

0

3.5

3.5

0

1 0.75

1 0.75

1 0

1

1

0

1 1

1 1

0 1

1

1

1

1.5 1.5 1.5

1.5 1.5 1.5

0 0 1.5

0 2

0 2

0 2

Ultrasound Session: Advanced Hemodynamics Vascular Potpourri 3:45 pm – 5:15 pm A Comprehensive Overview of Lymphedema Skin Changes Every Vein Specialist Should Recognize Society for Vascular Ultrasound (SVU) Symposium SATURDAY, NOVEMBER 4 7:30 am – 8:30 am Aesthetics in a Phlebology Practice Compression Workshop in Venous Disease & Lymphedema Meet the Experts in Venous Ultrasonography Pathways to Vein Center Accreditation Sclerotherapy Workshop 8:45 am – 10:45 am General Session 11:15 am – 12:45 pm Abstract Session II The Phlebology Office Ultrasound Session: Sonography in the Intervention Room 1:45 pm – 3:45 pm American Venous Forum (AVF) Symposium International Union of Phlebology (UIP) Symposium Society for Vascular Medicine (SVM) Symposium Ultrasound Session: Abdominal Venous Evaluation 4:15 pm – 5:45 pm Challenging Clinical Case Studies Everything You Want to Know About Lipedema Isolated Femoral-Popliteal Disease in Patients with CVI Mishaps & Misadventures – Managing/Avoiding Complications Ultrasound Session: Case Studies SUNDAY, NOVEMBER 5 8:00 am – 9:30 am Practice Management Symposium Part I Superficial Venous Disease Consensus & Controversies Venous Thromboembolism 9:45 am – 12:00 am

2017

31ST ANNUAL CONGRESS

2 2

2 2

0 0

1.5 1.5 1.5

1.5 1.5 1.5

1.5 1.5 0

1

1

1

1

1

1

1 1 1

1 1 1

0 1 1

1.5

1.5

1.5

1.5 1.5

1.5 1.5

0 1.5

1.5

1.5

0

2 2 2 2

2 2 2 2

0 0 0 0

1.5 1.5 1

1.5 1.5 1

1.5 0 0

1.5

1.5

1.5

1.5

1.5

0

1.5 1.5 1.5

1.5 1.5 1.5

1.5 1.5 1.5

Challenging Case Post-Mortem: Take Your Best Shot! Practice Management Symposium Part II

2.25 2.25

2.25 2.25

2.25 2.25

ROOM CHANGES The following session room assignments have been changes since the pocket schedule went to print. The locations listed in the mobile app are correct. Saturday, November 4 • Women in Phlebology Luncheon will now take place in Room 308 • ACP Texas Two-Step After Party will now take place off-site at The Vaughn 310-C Colorado Street – up on the rooftop Sunday, November 5 • Practice Management Symposium: People. Process. Payment will now take place in Lone Star Ballroom D/E. • Superficial Venous Disease Consensus & Controversies will now take place in Room 203/204.

2017

31ST ANNUAL CONGRESS

Recommend Documents
expressions, oxidative stress, and systemic inflammation in rats on an atherogenic diet. Eamon Laird, Trinity College. Poster 25: Holo-TC but not serum B12 ...

Streamspool. Streams Pool. 10. Line 2 from top message for message from. 10. Line 6 in last paragraph do match don't match. 36. Line 2 in second paragraph.

lectin, soluble vascular adhesion molecule 1 (sVCAM-1), and soluble intercellular cell adhesion molecule 1 (sICAM-1) concentrations were measured by commercial ELISA kits (Biosource International). High-sensitivity C-reactive protein (CRP) concentrat

Nov 11, 2016 - (B(·, ·), (l(·)). B(·, ·), l(·). 84. Theorem 3.11. B(φ, v) − l(v) = be. B(φ, v) − l(v)=0be. 87. Line 2 differential A operator differential operator A. 94. Line 5.

Mar 14, 2018 - Validation operator input port label exa replaces tra and output port label per replaces ave. Any references to X-Validation or X-Prediction ...

The cross reference '23.35' in the last line of paragraph 20.14 should read '25.35'. Table of Cases. The entry for 'The Global Santosh' should be amended as ...

Dec 31, 2012 - Phase II cities in that county. Because it is not a tipped county, unincorporated areas of. Caldwell County that are not otherwise subject to State ...

Apr 20, 2018 - corrected as follows: o “To utilize these features of online reporting, Special Codes must be marked in the Special Codes, Other Groups ...